Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2006 Dec 19

PMID 17173104

Citations 10

Authors

Francesco Chiappelli

Audrey M Navarro

David R Moradi

Ercolano Manfrini

Paolo Prolo

Affiliations

Soon will be listed here.

Abstract

This paper presents the novel domain of evidence-based research (EBR) in the treatment of patients with Alzheimer's disease (AD) from the perspective of traditional medicine and of complementary and alternative medicine. In earlier lectures we have described the process of evidence-based medicine as a methodological approach to clinical practice that is directed to aid clinical decision-making. Here, we present a practical example of this approach with respect to traditional pharmacological interventions and to complementary and alternative treatments for patients with AD.

Citing Articles

Marine invertebrate natural products for anti-inflammatory and chronic diseases.

Senthilkumar K, Kim S Evid Based Complement Alternat Med. 2014; 2013:572859.

PMID: 24489586 PMC: 3893779. DOI: 10.1155/2013/572859.

Assessment of risk of bias in translational science.

Barkhordarian A, Pellionisz P, Dousti M, Lam V, Gleason L, Dousti M J Transl Med. 2013; 11:184.

PMID: 23927081 PMC: 3751044. DOI: 10.1186/1479-5876-11-184.

Reliability of Quality Assessments in Research Synthesis: Securing the Highest Quality Bioinformation for HIT.

Chiappelli F, Phil A, Arora R, Phi L, Giroux A, Uyeda M Bioinformation. 2012; 8(14):691-4.

PMID: 23055612 PMC: 3449364. DOI: 10.6026/97320630008691.

Expanding the Grading of Recommendations Assessment, Development, and Evaluation (Ex-GRADE) for Evidence-Based Clinical Recommendations: Validation Study.

Phi L, Ajaj R, Ramchandani M, Brant X, Oluwadara O, Polinovsky O Open Dent J. 2012; 6:31-40.

PMID: 22303416 PMC: 3269009. DOI: 10.2174/1874210601206010031.

Evidence-based dentistry in a developing economy - the Nigerian example.

Akadiri O, Adeyemo W Open Dent J. 2010; 4:51-4.

PMID: 20871751 PMC: 2944990. DOI: 10.2174/1874210601004020051.

References

Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius H . Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003; 348(14):1333-41. DOI: 10.1056/NEJMoa013128. View

Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E . Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 2004; 363(9427):2105-15. DOI: 10.1016/S0140-6736(04)16499-4. View

Chapman P, Shaw R . Normative dental treatment needs of Alzheimer patients. Aust Dent J. 1991; 36(2):141-4. DOI: 10.1111/j.1834-7819.1991.tb01343.x. View

Imbimbo B, Lucca U, Lucchelli F, Alberoni M, Thal L . A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 1999; 12(4):313-22. DOI: 10.1097/00002093-199812000-00011. View

Provinciali L, Minciotti P, Ceravolo G, Angeleri F, Sanguinetti C . Transcranial Doppler sonography as a diagnostic tool in vascular dementia. Eur Neurol. 1990; 30(2):98-103. DOI: 10.1159/000117320. View

Maurer K, Ihl R, Dierks T, Frolich L . Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res. 1998; 31(6):645-55. DOI: 10.1016/s0022-3956(97)00022-8. View

Evans D . Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990; 68(2):267-89. View

Landry M, Sibbald W . From data to evidence: evaluative methods in evidence-based medicine. Respir Care. 2001; 46(11):1226-35. View

Raskind M, Peskind E, Truyen L, Kershaw P, Damaraju C . The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial. Arch Neurol. 2004; 61(2):252-6. DOI: 10.1001/archneur.61.2.252. View

10.

Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A . Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2005; 7(3):221-32. DOI: 10.3233/jad-2005-7304. View

11.

Rosler M, Anand R, Gauthier S, Agid Y, Dal-Bianco P, Stahelin H . Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ. 1999; 318(7184):633-8. PMC: 27767. DOI: 10.1136/bmj.318.7184.633. View

12.

Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E . A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001; 57(4):613-20. DOI: 10.1212/wnl.57.4.613. View

13.

Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A . A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 2001; 57(3):489-95. DOI: 10.1212/wnl.57.3.489. View

14.

Hake A . The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches. Semin Neurol. 2002; 22(1):71-4. DOI: 10.1055/s-2002-33050. View

15.

Chiappelli F, Prolo P, Cajulis O . Evidence-based research in complementary and alternative medicine I: history. Evid Based Complement Alternat Med. 2005; 2(4):453-8. PMC: 1297495. DOI: 10.1093/ecam/neh106. View

16.

Sano M, Ernesto C, Thomas R, Klauber M, Schafer K, Grundman M . A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997; 336(17):1216-22. DOI: 10.1056/NEJM199704243361704. View

17.

Akobeng A . Principles of evidence based medicine. Arch Dis Child. 2005; 90(8):837-40. PMC: 1720507. DOI: 10.1136/adc.2005.071761. View

18.

Kalaria R, Cohen D, Premkumar D . Cellular aspects of the inflammatory response in Alzheimer's disease. Neurodegeneration. 1996; 5(4):497-503. DOI: 10.1006/neur.1996.0069. View

19.

Thal L, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E . Idebenone treatment fails to slow cognitive decline in Alzheimer's disease. Neurology. 2003; 61(11):1498-502. DOI: 10.1212/01.wnl.0000096376.03678.c1. View

20.

Lombardi V, Garcia M, Rey L, Cacabelos R . Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J Neuroimmunol. 1999; 97(1-2):163-71. DOI: 10.1016/s0165-5728(99)00046-6. View